The NHS has begun a new financial year amid considerable acrimony and massive disruption as many of its trusts grapple …
Novartis has launched an innovative new campaign to raise awareness of leukaemia treatment among the UK's general practitioners; a move …
Novartis has signed a deal to develop and market Servier's new antidepressant and agomelatine for the US market.The drug has …
Novartis says trials of its new hepatitis drug in Chinese patients show it to be superior to standard treatment, in …
Sanofi-Aventis has won US approval to market its drug Taxotere as a treatment for stomach cancer, and says it is …
Nearly half of all doctors are unaware that the UK pharmaceutical industry operates a code of practice, a new survey …
Competition watchdog the Office of Fair Trading is to continue its investigation into how prescription medicines are priced in the …
Doctors' leaders have spoken out against cutbacks to the medical training budget, which they warn could seriously harm patient services.The …
The management of Schering has unveiled a surprise merger deal with fellow German pharmaceutical company Bayer, in a move designed …
Patient groups have condemned the new GP contract, saying it ignores a potentially life-threatening condition in tens of thousands of …
Recruitment company Levy Associates have become one of the UK's fastest growing companies thanks to their success in matching talented …
Roche is using a new automated system to identify the best job candidates faster, using online screening developed by technology …
Servier says new data on its osteoporosis treatment Protelos shows it reduces women's long-term risk of bone fractures by a …
Is e-marketing dropping off pharma marketing's radar, or are opportunities going begging? Three or four years ago, it was the …
A new deal between the UK government and the pharmaceutical industry to ensure faster and wider access to new medicines …
Two men involved in a UK clinical trial of new anti-inflammatory drug remain in a critical condition more than three …
UK Biobank, the world’s largest and most detailed study of how genes, lifestyle and environment affect risks of developing disease, …
Eleven patients have died in a study investigating Eisai/Pfizer's Aricept in the treatment of vascular dementia – but investigators say …
Fears that the pharmaceutical industry could be on a collision course with Europe's healthcare payers over new high priced medicines …
Most companies are anxious to court the media to ensure a clearer understanding of their business focus. However, the first …